Alzheimer's disease (AD) is a neurodegenerative disease responsible for almost half of all
dementia cases in the world and progressively increasing. The etiopathology includes …

Alzheimer's disease (AD) is the most common neurodegenerative diseases. Increasing
studies have demonstrated the critical importance for redox proteins mediating neuronal …

Background Estrogen deficiency leads to mitochondrial defects that precede Alzheimer's
disease (AD)-associated pathological changes in a postmenopausal mouse model …

Introduction This increasing body of literature indicates that menopause hormonal
replacement therapy (MHT) may substantially mitigate the risk of developing late‐life …

More women have Alzheimer disease (AD) than men, but the reasons for this phenomenon
are still unknown. Including women in clinical research and studying their biology is key to …

Alzheimer's disease is the most common type of dementia, being highly prevalent in elderly
women. The advanced progression may be due to decreased hormone synthesis during …

Background: Estrogen deficiency contributes to the development of Alzheimer's disease
(AD) in menopausal women. In the current study, we examined the impact of estrogen …

Alzheimer's disease (AD) affects more women than men, with women throughout the
menopausal transition potentially being the most under researched and at-risk group. Sleep …

A deficiency in B-vitamins is known to lead to persistent developmental defects in various
organs during early life. The nervous system is particularly affected with functional …

Increasing evidence suggests that female individuals have a higher Alzheimer's disease
(AD) risk associated with post-menopausal loss of circulating estradiol (E2). However …